Symposia & Webinars
Sequential treatment strategy in dyslipidemia vs earlier use of combination therapies: decision-making factors

Watch the recording of the ESC 2021 Satellite Symposium sponsored by Servier on factors important for decision-making in dyslipidemia with Alberto Zambon, Evangelos Liberopoulos, and Francois Schiele.
The program:
- Introduction
Alberto Zambon - Reasons for a sequential treatment strategy in dyslipidemia
Evangelos Liberopoulos - Should we encourage earlier and broader use of combination therapies in dyslipidemia?
Francois Schiele - Discussion
Zambon, Liberopoulos, Schiele